Private health plans paid hospitals 254% of what Medicare would pay during 2022: RAND Corporation
2024 MAY 29 (NewsRx) -- By a
Some states (
Even as the number of hospitals and insurance claims analyzed has grown across multiple rounds of the RAND Hospital Price Transparency Study the state-level average price has remained above 200% of Medicare -- from 247% of Medicare prices in 2018 to 224% in 2020 and to 254% in 2022.
“The utility of this work is that it gives employers important tools they can use to become better-informed purchasers of health care services,” said
Spending on hospital services accounted for 42% of total
Recent federal policies require hospitals to post prices for at least 300 “shoppable” services and that insurers post their full set of negotiated rates. However, many hospitals have not complied with these policies, and insurer-posted data contain duplicative information that often makes file sizes so large that they are difficult to use.
The RAND study found that in 2022 relative prices for inpatient hospital facility services averaged 255% of Medicare prices, outpatient hospital facility services averaged 289%, and associated professional services averaged 188% of what Medicare would have paid for the same services.
Prices for common outpatient services performed in ambulatory surgical centers averaged 170% of Medicare payments.
“The widely varying prices among hospitals suggests that employers have opportunities to redesign their health plans to better align hospital prices with the value of care provided,” said Brian Briscombe, who currently leads the RAND hospital price transparency project. “However, price transparency alone will not lead to changes if employers do not or cannot act upon price information.”
For the first time, the RAND study also reports the cost of specialty prescription drugs, comparing prices for medications administered in hospital settings versus those that are administered in physician offices.
Weighting each state’s prices equally, RAND researchers found that commercial insurance prices for select administered drugs received in a hospital setting averaged 278% of average sales price, compared with 106% of average sales price paid by Medicare.
The report explains that very little variation in prices is explained by each hospital’s share of patients covered by Medicare or Medicaid. A larger portion of price variation is explained by hospital market power.
The RAND study is based on information about more than 4,000 hospitals in 49 states and
The analysis includes facility and professional claims for inpatient and outpatient services provided by both Medicare-certified short-stay hospitals and other facility types. Researchers analyzed health care claims obtained from self-insured employers, 12 state all-payer claims databases and from health insurance plans that chose to participate. In total, the study analyzed approximately 6% of
For each private claim, researchers re-priced the service using Medicare’s grouping and pricing formulas. Each claim was benchmarked to what would be paid by Medicare -- the federal insurance plan for Americans aged 65 and older -- as a way to assess variation in health care costs nationally. Medicare prices are designed to provide modest profit margins for efficient hospitals.
Unlike many other studies that have examined health care price variation, the RAND study reports prices and identifies hospitals and groups of hospitals under joint ownership (hospital systems) by name.
A detailed list of both relative and standardized prices for each facility, identified by name and Medicare Provider Number, is included in the report’s supplemental material. The supplemental material also includes CMS Hospital Compare star ratings for those hospital facilities.
Support for the study was provided by the
The report, “Prices Paid to Hospitals by Private Health Plans: Findings from Round 5 of an Employer-Led Transparency Initiative,” is available at www.rand.org. Authors of the report are
RAND Health Care promotes healthier societies by improving health care systems in
(Our reports deliver fact-based news of research and discoveries from around the world.)



Congressional Research Service Issues Insight White Paper on Federal Flood Risk Management Standard
Dalian Medical University Reports Findings in Cancer (The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data): Cancer
Advisor News
- Pay or Die: The scare tactics behind LA County’s Measure ER tax increase
- How to listen to what your client isn’t saying
- Strong underwriting: what it means for insurers and advisors
- Retirement is increasingly defined by a secure income stream
- Addressing the ‘menopause tax:’ A guide for advisors with female clients
More Advisor NewsAnnuity News
- MassMutual turns 175, Marking Generations of Delivering on its Commitments
- ALIRT Insurance Research: U.S. Life Insurance Industry In Transition
- My Annuity Store Launches a Free AI Annuity Research Assistant Trained on 146 Carrier Brochures and Live Annuity Rates
- Ameritas settles with Navy vet in lawsuit over disputed annuity sale
- NAIC annuity guidance updates divide insurance and advisory groups
More Annuity NewsHealth/Employee Benefits News
- Health insurance for famers
- Business People: General Mills veteran Dana McNabb named COO
- CONFEREES ADOPT COMMERCE PACKAGE WITH MEAT RAFFLE INCREASE, NO INSURANCE LOOPHOLE FIX
- GLP-1 Drug Costs Cited as Heights Schools Hike Taxes and Cut Staff
- Pay or Die: The scare tactics behind LA County’s Measure ER tax increase
More Health/Employee Benefits NewsLife Insurance News
- 2025 Insurance Abstracts
- AM Best Affirms Credit Ratings of Berkshire Hathaway Life Insurance Company of Nebraska and First Berkshire Hathaway Life Insurance Company
- Generational expectations: A challenge for the industry
- Greg Lindberg asks NC judge for no jail time in bribery, fraud cases
- National Life Group Names Brenda Betts to Its Board of Directors
More Life Insurance News